Compare NVTS & CLOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVTS | CLOV |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.4B |
| IPO Year | 2020 | 2020 |
| Metric | NVTS | CLOV |
|---|---|---|
| Price | $7.88 | $4.45 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $14.39 | $5.50 |
| AVG Volume (30 Days) | ★ 12.4M | 4.2M |
| Earning Date | 11-03-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.03 |
| EPS | N/A | ★ 0.10 |
| Revenue | $45,916,000.00 | ★ $1,924,308,000.00 |
| Revenue This Year | $4.02 | $53.58 |
| Revenue Next Year | $52.24 | $19.34 |
| P/E Ratio | ★ N/A | $46.70 |
| Revenue Growth | N/A | ★ 40.34 |
| 52 Week Low | $6.85 | $1.58 |
| 52 Week High | $34.17 | $5.59 |
| Indicator | NVTS | CLOV |
|---|---|---|
| Relative Strength Index (RSI) | 47.26 | 53.18 |
| Support Level | $7.65 | $4.17 |
| Resistance Level | $9.57 | $4.89 |
| Average True Range (ATR) | 0.60 | 0.23 |
| MACD | 0.08 | -0.03 |
| Stochastic Oscillator | 86.07 | 67.80 |
Navitas Semiconductor Corp develops ultra-efficient gallium nitride (GaN) semiconductors that are revolutionizing power electronics. GaN power ICs integrate GaN power with drive, control, and protection to enable fast charging, high power density, and energy savings for mobile, consumer, enterprise, eMobility, and new energy markets. The company operates as one reportable segment, the design, development, manufacture, and marketing of integrated circuits and related components. Geographically, the company operates in Hong Kong, China, Europe, the United States, Rest of Asia, and Others. The majority of revenue is generated from Hong Kong.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.